Zynrelef
Drug Postoperative Pain
NDC 47426-301-02
General payments
$2,530,516
Research payments
$5,407,138
Through program year 2022, $2,530,516 in general payments and $5,407,138 in research payments were reported against Zynrelef (Postoperative Pain).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $1,396,013 | 7,344 |
| 2022 | Research | $4,672,192 | 276 |
| 2021 | General | $1,134,504 | 5,497 |
| 2021 | Research | $734,945 | 121 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 108 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
12,841 general · 397 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.